LRAD ($GNSS) is expected to release its quarterly earnings data on Tuesday, December 9th after market close, per Finnhub. Analysts are expecting revenue of $20,247,000 and earnings of -$0.03 per share.
You can see Quiver Quantitative's $GNSS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LRAD Hedge Fund Activity
We have seen 17 institutional investors add shares of LRAD stock to their portfolio, and 31 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INTEGRITY WEALTH ADVISORS, INC. added 6,338,184 shares (+91.5%) to their portfolio in Q3 2025, for an estimated $15,528,550
- FNY INVESTMENT ADVISERS, LLC added 164,048 shares (+32.1%) to their portfolio in Q2 2025, for an estimated $283,803
- CITADEL ADVISORS LLC added 155,272 shares (+650.8%) to their portfolio in Q3 2025, for an estimated $380,416
- MARINER, LLC removed 135,837 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $332,800
- MANATUCK HILL PARTNERS, LLC removed 117,910 shares (-7.2%) from their portfolio in Q3 2025, for an estimated $288,879
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 116,393 shares (+174.1%) to their portfolio in Q3 2025, for an estimated $285,162
- FI3 FINANCIAL ADVISORS, LLC removed 100,000 shares (-17.2%) from their portfolio in Q3 2025, for an estimated $245,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LRAD Analyst Ratings
Wall Street analysts have issued reports on $GNSS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Ascendiant Capital issued a "Buy" rating on 10/06/2025
To track analyst ratings and price targets for LRAD, check out Quiver Quantitative's $GNSS forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.